Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
06/14/2000 | EP1007964A1 FORMATION AND USE OF PRION PROTEIN (PrP) COMPLEXES |
06/14/2000 | EP1007743A2 Enzymes mixture |
06/14/2000 | EP1007741A1 Method for marking solid, liquid or gaseous substances |
06/14/2000 | EP1007738A1 Methods for analyzing ltc4 synthase polymorphisms and diagnostic use |
06/14/2000 | EP1007737A1 System for providing a polymorphism database |
06/14/2000 | EP1007736A1 Methods and compositions for modulating melting temperatures of nucleic acids |
06/14/2000 | EP1007735A1 Anti-sense oligonucleotide pharmacological agents |
06/14/2000 | EP1007732A1 Evolution of whole cells and organisms by recursive sequence recombination |
06/14/2000 | EP1007728A1 Nucleic acid amplification method: hybridization signal amplification method (hsam) |
06/14/2000 | EP1007727A1 Method of dna shuffling with polynucleotides produced by blockingor interrupting a synthesis or amplification process |
06/14/2000 | EP1007726A1 Method and compositions for controlling gene expression |
06/14/2000 | EP1007725A1 Padlock probe detection |
06/14/2000 | EP1007724A1 Cryptosporidium detection method |
06/14/2000 | EP1007721A1 Process for preparing obesity protein analogs |
06/14/2000 | EP1007720A1 Dendritic cell hybrids |
06/14/2000 | EP1007719A1 Methods of making an rnp particle having nucleotide integrase activity |
06/14/2000 | EP1007718A1 Polymerase enhancing factor (pef) extracts, pef protein complexes, isolated pef protein, and methods for purifying and identifying |
06/14/2000 | EP1007717A2 Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta |
06/14/2000 | EP1007716A1 Use of lentiviral vectors for antigen presentation in dendritic cells |
06/14/2000 | EP1007715A2 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
06/14/2000 | EP1007714A1 Regulatory sequences capable of conferring expression of a heterologous dna sequence in endothelial cells in vivo and uses thereof |
06/14/2000 | EP1007713A2 Dna expression in transfected cells and assays carried out in transfected cells |
06/14/2000 | EP1007712A1 The use of mixed duplex oligonucleotides to effect localized genetic changes in plants |
06/14/2000 | EP1007711A1 Für drosomycin kodierendes chimäres gen, dieses gen enhaltender vektor und herstellung von krankheitsresistenten transgenen pflanze |
06/14/2000 | EP1007710A1 A sunflower albumin 5' regulatory region for the modification of plant seed lipid composition |
06/14/2000 | EP1007709A1 Pathogen-induced plant promoters |
06/14/2000 | EP1007708A1 Sense intron inhibition of starch branching enzyme expression |
06/14/2000 | EP1007707A1 Antisense intron inhibition of starch branching enzyme expression |
06/14/2000 | EP1007706A1 Rna binding protein and binding site useful for expression of recombinant molecules |
06/14/2000 | EP1007705A1 Sugarcane bacilliform virus promoter |
06/14/2000 | EP1007704A2 Method for the induction of genetic parthenocarpy in plants |
06/14/2000 | EP1007703A1 Methods of conferring ppo-inhibiting herbicide resistance to plants by gene manipulation |
06/14/2000 | EP1007702A1 Method for increasing the gene expression of saccharose synthase |
06/14/2000 | EP1007701A1 Resistance mechanisms to ic type r/m bacteriophages of lactic acid bacteria |
06/14/2000 | EP1007700A1 Immunological detection of prions |
06/14/2000 | EP1007699A1 Peptide-enhanced transfections |
06/14/2000 | EP1007698A1 Expression of heterologous proteins |
06/14/2000 | EP1007697A2 Production of proteins in eggs |
06/14/2000 | EP1007696A1 Il-13 receptor specific chimeric proteins and uses thereof |
06/14/2000 | EP1007695A2 Rab proteins |
06/14/2000 | EP1007694A2 Esterases, dna encoding therefor and vectors and host cells incorporating same |
06/14/2000 | EP1007693A1 Pak kinase genes and polypeptides and methods of use thereof |
06/14/2000 | EP1007691A1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids |
06/14/2000 | EP1007690A2 Genes encoding enzymes for lignin biosynthesis and uses thereof |
06/14/2000 | EP1007689A2 Production of polyketides in plants |
06/14/2000 | EP1007688A2 Desaturase antigen of mycobacterium tuberculosis |
06/14/2000 | EP1007687A1 Fiv vaccine |
06/14/2000 | EP1007686A1 Tuberculosis vaccine |
06/14/2000 | EP1007685A2 Surface exposed proteins from chlamydia pneumoniae |
06/14/2000 | EP1007684A2 Method and means for modulating plant cell cycle proteins and their use in controlling plant cell growth |
06/14/2000 | EP1007683A1 Coffee storage proteins |
06/14/2000 | EP1007682A1 Novel nucleic acid molecules and uses therefor |
06/14/2000 | EP1007681A1 Method of increasing the iron content of plant cells |
06/14/2000 | EP1007680A2 Single and double chain antibodies to the egf receptor, derivatives thereof and their use |
06/14/2000 | EP1007679A1 Recombinant human erythropoietin with advantageous glycosylation profile |
06/14/2000 | EP1007678A1 Kringle1 |
06/14/2000 | EP1007677A2 Protease-related protein |
06/14/2000 | EP1007676A1 High affinity immunoglobulin e receptor-like protein |
06/14/2000 | EP1007675A1 Porcine mhc class i genes and uses thereof |
06/14/2000 | EP1007674A1 Testis-specific transcription factor zgcl-1 |
06/14/2000 | EP1007673A1 Novel bone mineralization proteins, dna, vectors, expression systems |
06/14/2000 | EP1007672A1 Intracellular glucocorticoid-induced leucine zippers modulators of apoptic cell death pathways |
06/14/2000 | EP1007671A1 Fanconi-gen ii |
06/14/2000 | EP1007670A2 Two human g-protein coupled receptors: ebv-induced gpcr 2 (ebi-2) and edg-1-like gpcr |
06/14/2000 | EP1007669A1 A novel cell surface receptor for hiv retroviruses, therapeutic and diagnostic uses |
06/14/2000 | EP1007668A1 Human pancreatitis-associated protein, pap-2 |
06/14/2000 | EP1007667A1 Nucleic acids encoding sperm antigens and reprosa-i polypeptides |
06/14/2000 | EP1007666A1 Neurturin receptor |
06/14/2000 | EP1007665A1 Two human homologues of galectin-5 |
06/14/2000 | EP1007664A1 Therapies involving mutated heat shock transcription factor |
06/14/2000 | EP1007663A2 Human proteins |
06/14/2000 | EP1007662A1 Method for induction of apoptotic cell death in malignant cells, through reduction of the rb to apoptosis inducing proteins ratio |
06/14/2000 | EP1007661A2 Secreted proteins and polynucleotides encoding them |
06/14/2000 | EP1007660A2 Secreted proteins and polynucleotides encoding them |
06/14/2000 | EP1007659A2 Tumor necrosis factor receptors 6 alpha & 6 beta |
06/14/2000 | EP1007658A2 Mdm2-specific antisense oligonucleotides |
06/14/2000 | EP1007657A2 Hiv-specific oligonucleotides and methods of their use |
06/14/2000 | EP1007656A1 Modified protein kinase a-specific oligonucleotides and methods of their use |
06/14/2000 | EP1007655A1 Rnase l activators and antisense oligonucleotides effective to treat rsv infections |
06/14/2000 | EP1007654A1 In vitro peptide or protein expression library |
06/14/2000 | EP1007653A1 Polypeptides comprising a coiled-coil and an addition site |
06/14/2000 | EP1007652A1 Transgenic animals with knocked-in vec receptor genes and uses thereof |
06/14/2000 | EP1007651A1 Transgenic mammals which produce oligosaccharides in their milk |
06/14/2000 | EP1007650A1 Pca3, pca3 genes, and methods of use |
06/14/2000 | EP1007649A1 Methods to screen for transcription factor-coactivator interactions |
06/14/2000 | EP1007648A1 Anti-obesity proteins |
06/14/2000 | EP1007647A1 High level of expression of ingap |
06/14/2000 | EP1007646A1 Protease variants and compositions |
06/14/2000 | EP1007645A1 Human serum inducible kinase (snk) |
06/14/2000 | EP1007643A2 1-alpha-hydroxylase |
06/14/2000 | EP1007641A1 Adenoviruses having altered hexon proteins |
06/14/2000 | EP1007640A1 New spumavirus isolated from humans |
06/14/2000 | EP1007639A1 GLUCOSE RESPONSIVE $g(b)-CELL LINE |
06/14/2000 | EP1007638A1 Kcnq potassium channels and methods of modulating same |
06/14/2000 | EP1007637A1 Methods for increasing the efficiency of recombinant aav product |
06/14/2000 | EP1007636A2 Cultures of human cns neural stem cells |
06/14/2000 | EP1007633A1 Avian primordial germ cell (pgc) cell line and a method for long term culturing thereof |
06/14/2000 | EP1007632A1 Isolation of bone and cartilage precursor cells |
06/14/2000 | EP1007628A1 Transgenic model for heart failure |
06/14/2000 | EP1007627A1 Novel extracellular serine protease |